FLT4 and myocardial infarction: Blocking VEGFR-3 signaling did not affect cardiac function; however, after MI, sVEGFR-3 mice had significantly higher mortality with intramyocardial hemorrhages, a reduced capability to respond to lymphangiogenic signals, and a modified structure of the infarcted area.